Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q05066: Variant p.Ser91Gly

Sex-determining region Y protein
Gene: SRY
Feedback?
Variant information Variant position: help 91 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Serine (S) to Glycine (G) at position 91 (S91G, p.Ser91Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In SRXY1. Any additional useful information about the variant.


Sequence information Variant position: help 91 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 204 The length of the canonical sequence.
Location on the sequence: help SRDQRRKMALENPRMRNSEI S KQLGYQWKMLTEAEKWPFFQ The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         SRDQRRKMALENPRMRNSEISKQLGYQWKMLTEAEKWPFFQ

Gorilla                       SRDQRRKMALENPRMRNSEISKQLGYQWKMLTEAEKWPFFQ

                              SRDQRRKMALENPQMQNSEISKQLGYQWKMLTEAEKWPFFE

Rhesus macaque                SRDQKRKMALENPKMRNSEISKQLGYQWKMLTEADKWPFFQ

Chimpanzee                    SRDQRRKMALENPRMRNSEISKQLGYQWKMLTEAEKWPFFQ

Mouse                         SRGERHKLAQQNPSMQNTEISKQLGCRWKSLTEAEKRPFFQ

Rat                           SRGERRKLAQQNPSMQNSEISKHLGYQWKSLTEAEKRPFFQ

Pig                           SRDQRRKVALENPQMQNSEISKWLGCKWKMLTEAEKRPFFE

Bovine                        SRERRRKVALENPKMKNSDISKQLGYEWKRLTDAEKRPFFE

Goat                          SRERRRKVALENPKLQNSEISKQLGYEWKRLTDAEKRPFFE

Sheep                         SRERRRKVALENPKLQNSEISKQLGYEWKRLTDAEKRPFFE

Cat                           SRDQRRKVALENPQTQNSEISKQLGYQWKMLTQAEKWPFFE

Horse                         SRDHRRKVALENPQLQNSEISKRLGCQWKMLTEAEKLPFFE

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 204 Sex-determining region Y protein
DNA binding 60 – 128 HMG box
Region 59 – 136 Sufficient for interaction with KPNB1
Mutagenesis 75 – 75 R -> N. Strongly reduces nuclear localization. Abolishes DNA-binding. Does not reduce interaction with KPNB1 and CAML.
Mutagenesis 76 – 76 R -> P. Reduces nuclear localization. Reduces DNA-binding. Does not reduce interaction with KPNB1 and CAML. Does not affectnuclear import.
Helix 87 – 98



Literature citations
Two novel SRY missense mutations reducing DNA binding identified in XY females and their mosaic fathers.
Schmitt-Ney M.; Thiele H.; Kaltwasser P.; Bardoni B.; Cisternino M.; Scherer G.;
Am. J. Hum. Genet. 56:862-869(1995)
Cited for: VARIANTS SRXY1 GLY-91 AND LEU-125;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.